Kellen J A, Mirakian A, Wong A
Department of Clinical Biochemistry, Sunnybrook Medical Centre, University of Toronto, Ontario, Canada.
In Vivo. 1988 Mar-Apr;2(2):155-7.
Single-chain urokinase-like plasminogen activators have been determined by an indirect method (after activation to urokinase by plasmin and chromogenic assay with S 2444) in the cytosol of a rat tumor model. Variants of the R 3230 AC rat mammary adenocarcinoma were studied, including a subline with increased metastatic potential established by lung colony assay. The cellular content of the UK precursor was found to be significantly higher in the metastatic variant. Plasminogen activator-mediated invasion and collagenolysis of cells with the metastatic phenotype may be regulated by the release of the precursor which lacks reactivity with inhibitors, its transient activation and subsequent inhibition of the urokinase formed.
通过间接方法(在纤溶酶激活为尿激酶并使用S 2444进行显色测定后)在大鼠肿瘤模型的细胞质中测定了单链尿激酶样纤溶酶原激活剂。研究了R 3230 AC大鼠乳腺腺癌的变体,包括通过肺集落测定法建立的具有增强转移潜能的亚系。发现转移变体中尿激酶原的细胞含量明显更高。具有转移表型的细胞中纤溶酶原激活剂介导的侵袭和胶原溶解可能受前体释放的调节,该前体与抑制剂无反应性,其短暂激活以及随后对形成的尿激酶的抑制。